Development of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 and performance of an improved AMPLICOR HIV-1 MONITOR test with isolates of diverse subtypes
- PMID: 10405401
- PMCID: PMC85282
- DOI: 10.1128/JCM.37.8.2557-2563.1999
Development of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 and performance of an improved AMPLICOR HIV-1 MONITOR test with isolates of diverse subtypes
Abstract
Accurate determination of plasma human immunodeficiency virus type 1 (HIV-1) RNA levels is critical for the effective management of HIV-1 disease. The AMPLICOR HIV-1 MONITOR Test, a reverse transcription-PCR-based test for quantification of HIV-1 RNA in plasma, was developed when little sequence information on HIV-1 isolates from outside North America was available. It has since become apparent that many non-subtype B isolates, particularly subtypes A and E, are detected inefficiently by the test. We describe here the AMPLICOR HIV-1 MONITOR Test, version 1.5, an upgraded test developed to minimize subtype-related variation. We also developed a panel of HIV-1 standards containing 30 HIV-1 isolates of subtypes A through G. The virus particle concentration of each cultured viral stock was standardized by electron microscopic virus particle counting. We used this panel to determine the performance of the original AMPLICOR HIV-1 MONITOR Test and version 1.5 of the test with HIV-1 subtypes A through G. The original test underestimated the concentration of HIV-1 subtype A, E, F, and G RNA by 10-fold or more, whereas version of the 1.5 test yielded equivalent quantification of HIV-1 RNA regardless of the subtype. In light of the increasing intermixing of HIV-1 subtypes worldwide, standardization of PCR-based tests against well-characterized viral isolates representing the full range of HIV-1 diversity will be essential for the continued utility of these important clinical management tools.
Figures


Similar articles
-
Evaluation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay using primary subtype A, C, and D isolates from Kenya.J Clin Microbiol. 2000 Jul;38(7):2688-95. doi: 10.1128/JCM.38.7.2688-2695.2000. J Clin Microbiol. 2000. PMID: 10878065 Free PMC article.
-
Efficiencies of four versions of the AMPLICOR HIV-1 MONITOR test for quantification of different subtypes of human immunodeficiency virus type 1.J Clin Microbiol. 1999 Jan;37(1):110-6. doi: 10.1128/JCM.37.1.110-116.1999. J Clin Microbiol. 1999. PMID: 9854073 Free PMC article.
-
Comparison of three commercial assays for the quantification of HIV-1 RNA in plasma from individuals infected with different HIV-1 subtypes.J Clin Virol. 1999 Oct;14(2):87-94. doi: 10.1016/s1386-6532(99)00053-0. J Clin Virol. 1999. PMID: 10588451
-
Quantitative and cost comparison of ultrasensitive human immunodeficiency virus type 1 RNA viral load assays: Bayer bDNA quantiplex versions 3.0 and 2.0 and Roche PCR Amplicor monitor version 1.5.J Clin Microbiol. 2000 Mar;38(3):1113-20. doi: 10.1128/JCM.38.3.1113-1120.2000. J Clin Microbiol. 2000. PMID: 10699005 Free PMC article.
-
Comparative analysis of HIV-1 viral load assays on subtype quantification: Bayer Versant HIV-1 RNA 3.0 versus Roche Amplicor HIV-1 Monitor version 1.5.J Acquir Immune Defic Syndr. 2002 Apr 1;29(4):330-9. doi: 10.1097/00126334-200204010-00002. J Acquir Immune Defic Syndr. 2002. PMID: 11917236
Cited by
-
Determination of HIV Status in African Adults With Discordant HIV Rapid Tests.J Acquir Immune Defic Syndr. 2015 Aug 1;69(4):430-8. doi: 10.1097/QAI.0000000000000610. J Acquir Immune Defic Syndr. 2015. PMID: 25835607 Free PMC article.
-
A novel anti-HIV active integrase inhibitor with a favorable in vitro cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferase metabolism profile.Antiviral Res. 2013 Jun;98(3):365-72. doi: 10.1016/j.antiviral.2013.04.005. Epub 2013 Apr 18. Antiviral Res. 2013. PMID: 23602851 Free PMC article.
-
Relationships between infectious titer, capsid protein levels, and reverse transcriptase activities of diverse human immunodeficiency virus type 1 isolates.J Virol. 2004 Oct;78(20):11130-41. doi: 10.1128/JVI.78.20.11130-11141.2004. J Virol. 2004. PMID: 15452233 Free PMC article.
-
PA-457: a potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing.Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13555-60. doi: 10.1073/pnas.2234683100. Epub 2003 Oct 22. Proc Natl Acad Sci U S A. 2003. PMID: 14573704 Free PMC article.
-
Neurological Response to cART vs. cART plus Integrase Inhibitor and CCR5 Antagonist Initiated during Acute HIV.PLoS One. 2015 Nov 10;10(11):e0142600. doi: 10.1371/journal.pone.0142600. eCollection 2015. PLoS One. 2015. PMID: 26555069 Free PMC article. Clinical Trial.
References
-
- Alaeus A, Leitner T, Lidman K, Albert J. Most HIV-1 genetic subtypes have entered Sweden. AIDS. 1997;11:199–202. - PubMed
-
- Alaeus A, Lidman K, Sonnerborg A, Albert J. Subtype-specific problems with quantification of plasma HIV-1 RNA. AIDS. 1997;11:859–865. - PubMed
-
- Brodine S K, Mascola J R, Weiss P J, Ito S I, Porter K R, Artenstein A W, Garland F C, McCutchan F E, Burke D S. Detection of diverse HIV-1 genetic subtypes in the USA. Lancet. 1995;346:1198–1199. - PubMed
-
- Carr J K, Salminen M O, Albert J, Sanders-Buell E, Gotte D, Birx D L, McCutchan F E. Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants. Virology. 1998;247:22–31. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical